Join us on the latest episode! Our Guest: Stella K. Vnook, CEO at Likarda.
What you'll get out of this episode:
- Stella Vnook, CEO of Likarda, discusses her transition from a science background to the business side of biotech and her journey to becoming CEO.
- Likarda specializes in core-shell spherification, creating beads with cells for targeted drug delivery, improving viability and efficacy.
- The company aims to enhance cell therapies, especially in liver cells and hormone therapy, and simplify cell transport logistics.
- Likarda's future goals include launching off-the-shelf products for osteoarthritis and advancing partnerships in cell therapy and regenerative medicine.
- Funding strategies and future plans involve a Series A funding round, non-dilutive funding, and efficient use of resources to scale up and innovate.
To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/vnook/
Company LinkedIn: https://www.linkedin.com/company/likarda-llc/
Website: https://likarda.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
